• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

KRAS 的调控作用由小非编码 RNA 和 SNARE 蛋白介导。

KRAS regulation by small non-coding RNAs and SNARE proteins.

机构信息

Program in Epithelial Biology, Stanford University, Stanford, CA, 94305, USA.

Program in Cancer Biology, Stanford University, Stanford, CA, 94305, USA.

出版信息

Nat Commun. 2019 Nov 11;10(1):5118. doi: 10.1038/s41467-019-13106-4.

DOI:10.1038/s41467-019-13106-4
PMID:31712554
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6848142/
Abstract

KRAS receives and relays signals at the plasma membrane (PM) where it transmits extracellular growth factor signals to downstream effectors. SNORD50A/B were recently found to bind KRAS and inhibit its tumorigenic action by unknown mechanisms. KRAS proximity protein labeling was therefore undertaken in SNORD50A/B wild-type and knockout cells, revealing that SNORD50A/B RNAs shape the composition of proteins proximal to KRAS, notably by inhibiting KRAS proximity to the SNARE vesicular transport proteins SNAP23, SNAP29, and VAMP3. To remain enriched on the PM, KRAS undergoes cycles of endocytosis, solubilization, and vesicular transport to the PM. Here we report that SNAREs are essential for the final step of this process, with KRAS localization to the PM facilitated by SNAREs but antagonized by SNORD50A/B. Antagonism between SNORD50A/B RNAs and specific SNARE proteins thus controls KRAS localization, signaling, and tumorigenesis, and disrupting SNARE-enabled KRAS function represents a potential therapeutic opportunity in KRAS-driven cancer.

摘要

KRAS 在质膜 (PM) 接收和传递信号,在那里它将细胞外生长因子信号传递到下游效应物。最近发现 SNORD50A/B 与 KRAS 结合,并通过未知机制抑制其致癌作用。因此,在 SNORD50A/B 野生型和敲除细胞中进行了 KRAS 邻近蛋白标记,结果表明 SNORD50A/B RNA 塑造了 KRAS 邻近蛋白的组成,特别是通过抑制 KRAS 与 SNARE 囊泡运输蛋白 SNAP23、SNAP29 和 VAMP3 的接近。为了保持在 PM 上的富集,KRAS 经历内吞、溶解和囊泡运输到 PM 的循环。在这里,我们报告说 SNARE 对于这个过程的最后一步是必不可少的,KRAS 定位于 PM 是由 SNARE 介导的,但被 SNORD50A/B 拮抗。因此,SNORD50A/B RNA 与特定 SNARE 蛋白之间的拮抗作用控制 KRAS 的定位、信号转导和致癌作用,破坏 SNARE 介导的 KRAS 功能代表了 KRAS 驱动的癌症中的一个潜在治疗机会。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58ab/6848142/b46f5d54650a/41467_2019_13106_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58ab/6848142/f1e5a5553629/41467_2019_13106_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58ab/6848142/79ad03251741/41467_2019_13106_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58ab/6848142/c7edba89e887/41467_2019_13106_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58ab/6848142/12a809dd8812/41467_2019_13106_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58ab/6848142/e544475bbdc5/41467_2019_13106_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58ab/6848142/7ca6848c5b37/41467_2019_13106_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58ab/6848142/b46f5d54650a/41467_2019_13106_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58ab/6848142/f1e5a5553629/41467_2019_13106_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58ab/6848142/79ad03251741/41467_2019_13106_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58ab/6848142/c7edba89e887/41467_2019_13106_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58ab/6848142/12a809dd8812/41467_2019_13106_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58ab/6848142/e544475bbdc5/41467_2019_13106_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58ab/6848142/7ca6848c5b37/41467_2019_13106_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58ab/6848142/b46f5d54650a/41467_2019_13106_Fig7_HTML.jpg

相似文献

1
KRAS regulation by small non-coding RNAs and SNARE proteins.KRAS 的调控作用由小非编码 RNA 和 SNARE 蛋白介导。
Nat Commun. 2019 Nov 11;10(1):5118. doi: 10.1038/s41467-019-13106-4.
2
The noncoding RNAs SNORD50A and SNORD50B-mediated TRIM21-GMPS interaction promotes the growth of p53 wild-type breast cancers by degrading p53.非编码 RNA SNORD50A 和 SNORD50B 介导的 TRIM21-GMPS 相互作用通过降解 p53 促进 p53 野生型乳腺癌的生长。
Cell Death Differ. 2021 Aug;28(8):2450-2464. doi: 10.1038/s41418-021-00762-7. Epub 2021 Mar 19.
3
The noncoding RNAs SNORD50A and SNORD50B bind K-Ras and are recurrently deleted in human cancer.非编码RNA SNORD50A和SNORD50B与K-Ras结合,且在人类癌症中经常发生缺失。
Nat Genet. 2016 Jan;48(1):53-8. doi: 10.1038/ng.3452. Epub 2015 Nov 23.
4
Past and Future Strategies to Inhibit Membrane Localization of the KRAS Oncogene.抑制KRAS癌基因膜定位的过去与未来策略
Int J Mol Sci. 2021 Dec 7;22(24):13193. doi: 10.3390/ijms222413193.
5
Components of the phosphatidylserine endoplasmic reticulum to plasma membrane transport mechanism as targets for KRAS inhibition in pancreatic cancer.磷脂酰丝氨酸内质网到质膜转运机制的组成部分作为胰腺癌中 KRAS 抑制的靶点。
Proc Natl Acad Sci U S A. 2021 Dec 21;118(51). doi: 10.1073/pnas.2114126118.
6
Comprehensive analysis of expression, subcellular localization, and cognate pairing of SNARE proteins in oligodendrocytes.少突胶质细胞中SNARE蛋白的表达、亚细胞定位及同源配对的综合分析
J Neurosci Res. 2009 Jun;87(8):1760-72. doi: 10.1002/jnr.22020.
7
An XIST-related small RNA regulates KRAS G-quadruplex formation beyond X-inactivation.一种与XIST相关的小RNA在X染色体失活之外调节KRAS G-四链体的形成。
Oncotarget. 2016 Dec 27;7(52):86713-86729. doi: 10.18632/oncotarget.13433.
8
Cholesterol transport from late endosomes to the Golgi regulates t-SNARE trafficking, assembly, and function.胆固醇从晚期内体向高尔基体的运输调节 t-SNARE 的运输、组装和功能。
Mol Biol Cell. 2011 Nov;22(21):4108-23. doi: 10.1091/mbc.E11-04-0332.
9
Endosomal sorting of VAMP3 is regulated by PI4K2A.VAMP3的内体分选受PI4K2A调控。
J Cell Sci. 2014 Sep 1;127(Pt 17):3745-56. doi: 10.1242/jcs.148809. Epub 2014 Jul 7.
10
Targeting plasma membrane phosphatidylserine content to inhibit oncogenic KRAS function.靶向质膜磷脂酰丝氨酸含量抑制致癌 KRAS 功能。
Life Sci Alliance. 2019 Aug 26;2(5). doi: 10.26508/lsa.201900431. Print 2019 Oct.

引用本文的文献

1
VAMP proteins: molecular architects in disease pathogenesis and therapeutic innovation.VAMP蛋白:疾病发病机制与治疗创新中的分子架构师
Med Oncol. 2025 Aug 6;42(9):411. doi: 10.1007/s12032-025-02969-x.
2
New insights into protein-protein interaction modulators in drug discovery and therapeutic advance.药物发现与治疗进展中蛋白质-蛋白质相互作用调节剂的新见解。
Signal Transduct Target Ther. 2024 Dec 6;9(1):341. doi: 10.1038/s41392-024-02036-3.
3
The ancestral type of the R-RAS protein has oncogenic potential.R-RAS 蛋白的原始类型具有致癌潜能。

本文引用的文献

1
MicroScale Thermophoresis (MST) for studying actin polymerization kinetics.用于研究肌动蛋白聚合动力学的微量热泳技术(MST)。
Biotechniques. 2017 Oct 1;63(4):187-190. doi: 10.2144/000114599.
2
MicroScale Thermophoresis: A Rapid and Precise Method to Quantify Protein-Nucleic Acid Interactions in Solution.微量热泳动法:一种快速精确地定量溶液中蛋白质-核酸相互作用的方法。
Methods Mol Biol. 2017;1654:151-164. doi: 10.1007/978-1-4939-7231-9_10.
3
A snoRNA modulates mRNA 3' end processing and regulates the expression of a subset of mRNAs.
Cell Mol Biol Lett. 2024 Feb 21;29(1):27. doi: 10.1186/s11658-024-00546-0.
4
Targeting KRAS mutations with HLA class II-restricted TCR for the immunotherapy in solid tumors.针对实体瘤中 HLA Ⅱ类限制 TCR 靶向 KRAS 突变的免疫治疗。
Front Immunol. 2023 May 23;14:1161538. doi: 10.3389/fimmu.2023.1161538. eCollection 2023.
5
Identifying SNARE Proteins Using an Alignment-Free Method Based on Multiscan Convolutional Neural Network and PSSM Profiles.基于多扫描卷积神经网络和 PSSM 图谱的无对齐方法鉴定 SNARE 蛋白。
J Chem Inf Model. 2022 Oct 10;62(19):4820-4826. doi: 10.1021/acs.jcim.2c01034. Epub 2022 Sep 27.
6
Small Nucleolar RNAs and Their Comprehensive Biological Functions in Hepatocellular Carcinoma.小核仁 RNA 及其在肝细胞癌中的全面生物学功能。
Cells. 2022 Aug 26;11(17):2654. doi: 10.3390/cells11172654.
7
High Grade of Amplification of Six Regions on Chromosome 2p in a Neuroblastoma Patient with Very Poor Outcome: The Putative New Oncogene .一名预后极差的神经母细胞瘤患者2号染色体短臂六个区域的高扩增:假定的新致癌基因
Cancers (Basel). 2021 Nov 18;13(22):5792. doi: 10.3390/cancers13225792.
8
siRNA-Loaded Hydroxyapatite Nanoparticles for Gene Silencing in Anti-Pancreatic Cancer Therapy.用于抗胰腺癌治疗中基因沉默的载小干扰RNA羟基磷灰石纳米颗粒
Pharmaceutics. 2021 Sep 8;13(9):1428. doi: 10.3390/pharmaceutics13091428.
9
KRAS-related long noncoding RNAs in human cancers.KRAS 相关长链非编码 RNA 与人类癌症。
Cancer Gene Ther. 2022 May;29(5):418-427. doi: 10.1038/s41417-021-00381-x. Epub 2021 Sep 6.
10
SCAMP2/5 as diagnostic and prognostic markers for acute myeloid leukemia.SCAMP2/5 作为急性髓系白血病的诊断和预后标志物。
Sci Rep. 2021 Aug 23;11(1):17012. doi: 10.1038/s41598-021-96440-2.
一种小核仁RNA(snoRNA)调节mRNA的3'末端加工并调控一部分mRNA的表达。
Nucleic Acids Res. 2017 Sep 6;45(15):8647-8660. doi: 10.1093/nar/gkx651.
4
AML1-ETO requires enhanced C/D box snoRNA/RNP formation to induce self-renewal and leukaemia.AML1-ETO 需要增强 C/D 盒 snoRNA/RNP 的形成,以诱导自我更新和白血病。
Nat Cell Biol. 2017 Jul;19(7):844-855. doi: 10.1038/ncb3563. Epub 2017 Jun 26.
5
Drugging RAS: Know the enemy.下药 RAS:知己知彼。
Science. 2017 Mar 17;355(6330):1158-1163. doi: 10.1126/science.aam7622. Epub 2017 Mar 16.
6
Multivalent Small-Molecule Pan-RAS Inhibitors.多价小分子泛RAS抑制剂
Cell. 2017 Feb 23;168(5):878-889.e29. doi: 10.1016/j.cell.2017.02.006.
7
Gene Essentiality Profiling Reveals Gene Networks and Synthetic Lethal Interactions with Oncogenic Ras.基因必需性分析揭示基因网络以及与致癌性Ras的合成致死相互作用。
Cell. 2017 Feb 23;168(5):890-903.e15. doi: 10.1016/j.cell.2017.01.013. Epub 2017 Feb 2.
8
Augmenting CRISPR applications in Drosophila with tRNA-flanked sgRNAs.利用tRNA侧翼的sgRNA增强CRISPR在果蝇中的应用。
Nat Methods. 2016 Oct;13(10):852-4. doi: 10.1038/nmeth.3972. Epub 2016 Sep 5.
9
Direct small-molecule inhibitors of KRAS: from structural insights to mechanism-based design.直接靶向 KRAS 的小分子抑制剂:从结构见解到基于机制的设计。
Nat Rev Drug Discov. 2016 Nov;15(11):771-785. doi: 10.1038/nrd.2016.139. Epub 2016 Jul 29.
10
Dual function of C/D box small nucleolar RNAs in rRNA modification and alternative pre-mRNA splicing.C/D 盒小核仁RNA在核糖体RNA修饰和前体信使RNA可变剪接中的双重功能
Proc Natl Acad Sci U S A. 2016 Mar 22;113(12):E1625-34. doi: 10.1073/pnas.1519292113. Epub 2016 Mar 8.